Skip to main content

The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.

Publication ,  Journal Article
Tailor, TD; Schmidt, RA; Eaton, KD; Wood, DE; Pipavath, SNJ
Published in: J Thorac Imaging
September 2015

PURPOSE: Our purpose was to evaluate whether pseudocavitation, characterized by round or oval areas of low attenuation in a lesion on computed tomography (CT), can help distinguish adenocarcinoma from other types of non-small cell lung cancer (NSCLC). We also sought to determine whether pseudocavitation is associated with lepidic growth on histopathology. MATERIALS AND METHODS: This retrospective HIPAA-compliant study was approved by our institutional review board. The need for informed consent was waived. CT scans and pathology records from 158 NSCLCs in 149 patients were retrospectively reviewed. The frequency of pseudocavitation was compared among types of NSCLC, specifically adenocarcinoma versus other types of NSCLC. Subgroup analysis of adenocarcinomas was performed to identify any difference in the frequency of pseudocavitation between adenocarcinomas with reported lepidic growth and those without lepidic growth. RESULTS: There was a significantly greater frequency of pseudocavitation in adenocarcinomas versus other types of NSCLC [19/86 (22.1%) vs. 4/72 (5.6%), P=0.007]. The sensitivity and specificity of the pseudocavitation sign for adenocarcinoma were 0.22 and 0.94, respectively. Among adenocarcinomas, the pseudocavitation sign was more frequent in tumors with lepidic growth versus those without lepidic growth [10/24 (41.7%) vs. 9/62 (14.5%), P=0.015]. CONCLUSIONS: Pseudocavitation at CT is more common in primary lung adenocarcinoma than in other types of NSCLC. It is also more common in adenocarcinomas with lepidic growth, suggesting a correlation between the imaging finding of pseudocavitation and the pathologic finding of lepidic growth. As the subtype of NSCLC guides treatment, predicting tumor pathology by imaging may improve diagnostic workup for patients with NSCLC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thorac Imaging

DOI

EISSN

1536-0237

Publication Date

September 2015

Volume

30

Issue

5

Start / End Page

308 / 313

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Sensitivity and Specificity
  • Retrospective Studies
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Male
  • Lung Neoplasms
  • Humans
  • Female
  • Carcinoma, Non-Small-Cell Lung
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tailor, T. D., Schmidt, R. A., Eaton, K. D., Wood, D. E., & Pipavath, S. N. J. (2015). The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth. J Thorac Imaging, 30(5), 308–313. https://doi.org/10.1097/RTI.0000000000000168
Tailor, Tina D., Rodney A. Schmidt, Keith D. Eaton, Douglas E. Wood, and Sudhakar N. J. Pipavath. “The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.J Thorac Imaging 30, no. 5 (September 2015): 308–13. https://doi.org/10.1097/RTI.0000000000000168.
Tailor TD, Schmidt RA, Eaton KD, Wood DE, Pipavath SNJ. The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth. J Thorac Imaging. 2015 Sep;30(5):308–13.
Tailor, Tina D., et al. “The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth.J Thorac Imaging, vol. 30, no. 5, Sept. 2015, pp. 308–13. Pubmed, doi:10.1097/RTI.0000000000000168.
Tailor TD, Schmidt RA, Eaton KD, Wood DE, Pipavath SNJ. The Pseudocavitation Sign of Lung Adenocarcinoma: A Distinguishing Feature and Imaging Biomarker of Lepidic Growth. J Thorac Imaging. 2015 Sep;30(5):308–313.

Published In

J Thorac Imaging

DOI

EISSN

1536-0237

Publication Date

September 2015

Volume

30

Issue

5

Start / End Page

308 / 313

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Sensitivity and Specificity
  • Retrospective Studies
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Male
  • Lung Neoplasms
  • Humans
  • Female
  • Carcinoma, Non-Small-Cell Lung